Body Fitness Health

Tuesday, January 4, 2011

[AlternativeAnswers] viral conjunctivitis

Any suggestions on how to treat viral conjunctivitis? I have been fighting
a bad cold virus for over a week now and none of my usual cold-fighting
treatments are working with this one, it is extremely resistant to eveything
I try - echinacea, garlic, colloidal silver etc etc. I have even had to
resort to strong cold/flu tablets and so far nothing has really worked, and
now to top it off I have viral conjunctivitis in both eyes! Am intending to
go to clinic this morning and make an appt to see Dr...hopefully today and
may have to resort this time to strong anti-biotics (ugghhh) as a last ditch
resort to ditch this damn virus.

cheers
Lyndall

__._,_.___

Reply to sender | Reply to group | Reply via web post | Start a New Topic

Messages in this topic (1)

Recent Activity:

New Members 22

Visit Your Group

*********************************************
Peacefulmind.com Sponsors Alternative Answers-

HEALING NATURALLY- Learn preventative and curative measure to take for many ailments at:

http://www.peacefulmind.com/ailments.htm
____________________________________________

-To INVITE A FRIEND to our healing community, copy and paste this address in an email to them:

http://health.groups.yahoo.com/group/AlternativeAnswers/subs_invite

___________________________________________
To ADD A LINK, RESOURCE, OR WEBSITE to Alternative Answers please Go to:

http://health.groups.yahoo.com/group/AlternativeAnswers/links

_____________________________________________
Community email addresses:
Post message: AlternativeAnswers@yahoogroups.com
Subscribe: AlternativeAnswers-subscribe@yahoogroups.com
Unsubscribe: AlternativeAnswers-unsubscribe@yahoogroups.com
List owner: AlternativeAnswers-owner@yahoogroups.com
_________________________________________
Shortcut URL to this page:
http://health.groups.yahoo.com/group/AlternativeAnswers

Switch to: Text-Only, Daily Digest • Unsubscribe • Terms of Use

__,_._,___

Monday, January 3, 2011

[AlternativeAnswers] American Red Cross Statement on XMRV and Chronic Fatigue Syndrome

American Red Cross Statement on XMRV and Chronic Fatigue Syndrome

National Headquarters
2025 E Street, N.W.
Washington, DC 20006
_www.redcross.org_ (http://www.redcross.org/)

Contact: Public Affairs Desk
FOR MEDIA ONLY
_media@usa.redcross.org_ (mailto:media@usa.redcross.org)
Phone: (202) 303-5551

WASHINGTON, Friday, December 03, 2010 — At present, there are no specific
federal recommendations regarding deferral of individuals with Chronic
Fatigue Syndrome (CFS) or other diseases that have been associated with Murine
Leukemia Virus-related virus (XMRV) infection. Nevertheless, in the
interest of patient and donor safety, the American Red Cross will defer
indefinitely any donor who reveals during the donor interview that they have been
diagnosed with CFS.
XMRV infection has been associated in some studies with prostate cancer
and chronic fatigue syndrome, but at the present time these disease
associations have yet to be confirmed.
There is currently insufficient data to conclude that XMRV is transmitted
through blood transfusion. However, the National Heart, Lung and Blood
Institute (NHLBI) Task force is conducting research to determine the frequency
of the virus in the donor population, whether it is transfusion-transmitted,
and whether recipients become infected and develop the disease.
An AABB Interorganizational Task Force is charged with reviewing all
available data, making recommendations for further action to assess the risk of
XMRV transmission through blood transfusion, develop mitigation strategies
as needed, and to provide information for blood donors, recipients and the
public.
The AABB Taskforce released _Association Bulletin #10-03_
(http://www.aabb.org/resources/publications/bulletins/Pages/ab10-03.aspx) in June 2010,
_recommending_ (http://www.aabb.org/pressroom/Pages/cfsrecommendation.aspx)
that blood collecting organizations — through the use of donor education
_materials_
(http://www.aabb.org/resources/publications/bulletins/Pages/CFSeducationalresources.aspx) available at the donation site — actively discourage
potential donors who have ever been diagnosed by a physician with chronic
fatigue syndrome (CFS), also known as chronic fatigue and immune
dysfunction syndrome (CFIDS) or myalgic encephalomyelitis (ME), from donating blood
or blood components. In addition, any donor with symptoms of CFS would be
deferred if, on the day of donation, they respond negatively to the question,
"Are you feeling well today?"
The Red Cross has implemented the AABB recommendations and has gone further
to implement indefinite deferral for donors who reveal a history of a
medical diagnosis of CFS.
_http://tiny.cc/2oibh_ (http://tiny.cc/2oibh)

[Non-text portions of this message have been removed]

__._,_.___

Reply to sender | Reply to group | Reply via web post | Start a New Topic

Messages in this topic (1)

Recent Activity:

New Members 22

Visit Your Group

Switch to: Text-Only, Daily Digest • Unsubscribe • Terms of Use

__,_._,___

[AlternativeAnswers] Nervous system Lyme disease.

J R Coll Physicians Edinb. 2010 Sep;40(3):248-255.

Nervous system Lyme disease.

Halperin JJ.

Department of Neurosciences, Overlook Hospital, 99 Beauvoir Avenue, Summit,
New Jersey 07902, USA. john.halperin@atlantichealth.org.

Lyme disease, the multi-system infection caused by the tick-borne
spirochaete Borrelia burgdorferi, can involve the nervous system, most
commonly causing, alone or in combination, lymphocytic meningitis or
abnormalities of cranial or peripheral nerves, the latter most typically
presenting as a painful radicular syndrome. Diagnosis is based on
appropriately used, standard serological tests; in instances where the
central nervous system is involved, cerebrospinal fluid assessment for
organism-specific antibodies can be useful. Treatment with any of several
standard regimens of oral or parenteral antimicrobials is highly effective.
Prolonged treatment beyond four weeks is rarely if ever warranted, and
carries significant risk.

http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=211
27770&retmode=ref&cmd=prlinks
PMID: 21127770 [PubMed - as supplied by publisher]

[Non-text portions of this message have been removed]